Blog
Launch-at-risk of generics not that risky anymore: when the intellectual property court will refuse to grant security to the holder of a patent for an original drug
The decision of June 4, 2024 of the Intellectual Property Division of the Regional Court in Warsaw handed in the case regarding rivoraxaban (reference no. XXII GWo 225/24), should be of interest to all producers of generics considering the so-called launch-at-risk. The launch-at-risk refers to a situation in which a generic product is introduced to the market while...
New regulations regarding proceedings to secure claims in intellectual property cases
Three years after the establishment of intellectual property courts in Poland, we are witnessing the first significant change in the procedure before them, primarily in the area of the proceedings to secure claims. On March 9, 2023, the Polish parliament adopted an act amending the Act - Code of Civil Procedure and certain other acts. The provisions that are of interest to us entered into force...